We turn APIs into scalable pharmaceutical gummy dosage forms
Pharmmies leads pharmaceutical gummy programs from feasibility and formulation through pilot scale-up, analytical and regulatory planning, GMP technology transfer, commercial manufacturing and supply coordination
A gummy drug product must perform as a pharmaceutical dosage form, not as confectionery. Dose loading, taste, process conditions, stability, analytical methods and the regulatory pathway must be addressed together from the beginning
Dose & Uniformity
Achieving the target dose while maintaining content uniformity, acceptable unit size and processability
Taste Masking
Controlling bitterness and API release without compromising dissolution or stability
Process & Stability
Managing heat, moisture, pH, texture, water activity, packaging and scale-up risks
Analytical & Regulatory Strategy
Defining appropriate specifications, dissolution, stability, clinical or bioequivalence needs and the development pathway.
Pharmaceutical-grade development
Child-Resistant Packaging Strategy
Pilot/Commercial-scale experience
Our formulations combine pharmaceutical-grade materials, appropriate taste-masking technologies and dosage-form expertise to support palatability, release performance, manufacturability and stability targets.
Pilot/Commercial-scale experience
Child-Resistant Packaging Strategy
Pilot/Commercial-scale experience
We support pilot-scale manufacturing, process learning, technology transfer and commercial GMP manufacturing through qualified equipment, CDMO and manufacturing partners.
Child-Resistant Packaging Strategy
Child-Resistant Packaging Strategy
Child-Resistant Packaging Strategy
We evaluate bottle and blister packaging options based on product stability, child resistance, dose protection, manufacturability and user requirements
Acetaminophen
Taste-masked Acetaminophen 80/160/250 mg gummies - Pain relief and fever treatment for pediatrics, child-resistant blister pack-Commercial launch 2027
Ibuprofen
Taste-masked Ibuprofen 100 mg gummies- Pain and fever treatment
Diphenhydramine
Taste-masked diphenhydramine 12.5 mg gummy development program for pediatric OTC applications
Methylphenidate
Methylphenidate IR 2.5 mg gummy concept
formulation feasibility and development pathway under evaluation
Tadalafil
Tadalafil 10 mg gummy concept - formulation feasibility, taste-masking strategy and regulatory pathway under evaluation.